PATENT CLAIM ANALYSIS

Application Number: 16006642
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability, solubility, or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 6):
The method of  claim 5 , wherein the acid inhibitor is esomeprazole.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16006692', '16006548', '15988104', '15984055', '16000701']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8261681291478744
- 35 USC 102 Novelty (BERT): 0.5523918375288761
- Combined Prediction Score: 0.7987904999859746
- Mean Citation Score: 391.908216
- Max Citation Score: 408.1611
- Similarity Product: 406.4333286486088

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test